Page last updated: 2024-09-03

n-methylisoindigotin and Inflammatory Bowel Diseases

n-methylisoindigotin has been researched along with Inflammatory Bowel Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, L; Cheng, J; Li, S; Liu, W; Shen, Y; Shi, K; Sun, Y; Wang, J; Wu, X; Xu, Q	1

Other Studies

1 other study(ies) available for n-methylisoindigotin and Inflammatory Bowel Diseases

Article	Year
Meisoindigo attenuates dextran sulfate sodium-induced experimental colitis via its inhibition of TAK1 in macrophages. International immunopharmacology, 2021, Volume: 101, Issue:Pt B Topics: Animals; Anti-Inflammatory Agents; Colitis; Dextran Sulfate; Humans; Indoles; Inflammatory Bowel Diseases; Macrophages; MAP Kinase Kinase Kinases; Mice; Mice, Inbred C57BL; Models, Animal; NF-kappa B; RAW 264.7 Cells	2021

Article

Year

Meisoindigo attenuates dextran sulfate sodium-induced experimental colitis via its inhibition of TAK1 in macrophages.

International immunopharmacology, 2021, Volume: 101, Issue:Pt B

Topics: Animals; Anti-Inflammatory Agents; Colitis; Dextran Sulfate; Humans; Indoles; Inflammatory Bowel Diseases; Macrophages; MAP Kinase Kinase Kinases; Mice; Mice, Inbred C57BL; Models, Animal; NF-kappa B; RAW 264.7 Cells

2021